Rachel L. Schweers

Katten Muchin Rosenman LLP

General

Experience20 yrs

Elite Ratings

--

Practice Areas

Biotech (14 cases)

Chemical Biotech (1 case)

Law Firms

Katten Muchin Rosenman LLP

rachel.schweers@katten.com

Ratings

Experience

Grade

Trend

DCT

L4

D

PTAB

--

--

--

CAFC

--

--

--

Cases

Case #	Court	Caption	Filed	Represent
1:24-CV-00064	D. DE	Eagle Pharma Inc v. Apotex Inc	01/17/24	Challenger :Apotex Corp	.
1:23-CV-00327	D. DE	Bayer IP GmbH v. Apotex Inc	03/24/23	Challenger :Apotex Corp	.
2:22-CV-07357	D. NJ	Astellas Pharma Inc v. Sun Pharmaceutical Industries Inc	12/16/22	Challenger :Sun Pharmaceutical Industries Ltd	.
1:22-CV-01596	D. DE	Bayer Pharma AG v. Apotex Inc	12/14/22	Challenger :Apotex Corp	.
2:22-CV-00216	D. VT	UCB Inc v. Mylan Tech Inc	12/12/22	Challenger :Mylan Technologies Inc	.
1:21-MD-03017	D. DE	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation	12/10/21	Challenger(L) :Apotex Corp	.
1:21-CV-01256	D. DE	Eagle Pharma Inc v. Slayback Pharma LLC	08/31/21	Challenger(W) :Apotex Corp	.
1:21-CV-00839	D. DE	PF Prism Imb BV v. Mylan Pharma Inc	06/09/21	Challenger :Mylan Pharmaceuticals Inc	.
1:21-CV-00314	D. DE	Bayer Pharma AG v. Mylan Pharma Inc	03/01/21	Challenger(L) :Apotex Corp	.
1:21-CV-00187	D. DE	Bial Portela & Ca SA v. Apotex Inc	02/10/21	Challenger :Apotex Corp	.

Ratings Trends

Practice Areas